The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project.

Headline
The Department of Labor July 22 released a proposed rule to modernize how group health plans deliver required disclosures. The proposal would create a safe…
Headline
The AHA provided comments July 21 to the Senate Committee on Health, Education, Labor and Pensions on price transparency, nursing workforce and rural…
Headline
The AHA provided comments to the House Energy and Commerce Committee July 21 on two price transparency bills the full committee…
Headline
The U.S. District Court for the District of Maryland July 16 enjoined eight provisions from the Centers for Medicare & Medicaid Services’ 2027 notice of…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Blog
Public
Americans experience healthcare affordability in different ways. Often, affordability is first considered in terms of health insurance premiums that fit within…